Monoclonal Antibody Drugs Fail To Improve Alzheimer's Disease Symptoms
The investigational drugs gantenerumab and solanezumab – both monoclonal antibody (mAb) therapeutics – failed to slow cognitive decline in patients with dominantly inherited Alzheimer’s disease (DIAD), a new trial has found.
EvoGenix Announces Antibody Collaboration with CSL
EvoGenix will apply its proprietary technologies to antibody products selected by CSL from its pipeline.
Moffitt and Inovio Announce Positive Results from Human Study of Plasmid DNA Delivery Using Electroporation
Collaborators encouraged by interim data from phase I clinical study of patients with malignant melanoma.
PrimeCell™ VP of Research and Development Available to Discuss Alternatives to Embryonic Stem Cells
As congress considers various approaches to stem cell research, PrimeCell offers technology that may accelerate the path to therapy.
Acolyte and Berthold form Marketing Alliance
Berthold will support distribution of Acolyte’s BacLite® RapiTECT range of enumeration assays.
Murex Announces Joint Development Agreement with GNS
Murex will utilize technology from Gene Network Sciences to create computer-based models that enhance identification and validation of cancer targets.
Bioheart and PharmaCell Open GMP Lab Facility in Europe
This lab is an advanced research facility that also has GMP cell production capabilities to support research related to Bioheart's adult muscle stem cell technology.
Tepnel Raises £1.2m for Completion of the Company’s new Facility in Livingston
This facility will incorporate pharmaceutical services including high throughput genotyping and protein analysis.
Fluidigm Topaz® System Expedites Structure Determination for the Hemagglutinin of the H5N1 Avian flu Virus
The goal of this research was to identify mutations that can permit influenza A viruses to cross the species barrier and adapt to a new host.
Experimental flu Vaccine Bypasses Needles by Patricia Reaney
PowderMed says it would move into bigger tests of its vaccine, which uses DNA from the flu virus to stimulate immunity.
Eisenberg Brothers will Distribute and Support Partek Software
Eisenberg Brothers will provide sales and marketing in Israel for each of Partek’s statistical analysis and data visualization software solutions.